This Article  • Full text  • PDF  • Correction  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Large-Scale Prospective Data

Anna Bennet, PhD; Emanuele Di Angelantonio, MD, MSc; Sebhat Erqou, MD, MPhil; Gudny Eiriksdottir, MSc; Gunnar Sigurdsson, MD, PhD; Mark Woodward, PhD; Ann Rumley, PhD; Gordon D. O. Lowe, MD, FRCP; John Danesh, FRCP, DPhil; Vilmundur Gudnason, MD, PhD

Arch Intern Med. 2008;168(6):598-608.

Background  Large-scale prospective data are needed to determine whether associations between lipoprotein(a) (Lp[a]) and coronary heart disease (CHD) risk are independent of established risk factors, to characterize the shape of this relationship, and to quantify associations in relevant subgroups.

Methods  Levels of Lp(a) were measured in samples obtained at baseline from 2047 patients who had first-ever nonfatal myocardial infarction or who died of CHD during the study and from 3921 control participants in the Reykjavik Study (n = 18 569), as well as in paired samples obtained 12 years apart from 372 participants to quantify within-person fluctuations.

Results  Baseline Lp(a) levels had little or no correlation with known cardiovascular risk factors, such as age, sex, total cholesterol level, and blood pressure. The Lp(a) values were highly consistent from decade to decade, with a regression dilution ratio (calculated on the log scale) of 0.92 (95% confidence interval, 0.85-0.99). The odds ratio for CHD, unaltered after adjustment for several established risk factors (age, sex, smoking status, blood pressure, total cholesterol, triglycerides level, diabetes mellitus, and body mass index), was 1.60 (95% confidence interval, 1.38-1.85) in a comparison of extreme thirds of baseline Lp(a) levels. Odds ratios were progressively higher with increasing Lp(a) levels and did not vary materially by several individual- or study-level characteristics.

Conclusions  There are independent, continuous associations between Lp(a) levels and risk of future CHD in a broad range of individuals. Levels of Lp(a) are highly stable within individuals across many years and are only weakly correlated with known risk factors. Further assessment of their possible role in CHD prevention is warranted.

Author Affiliations: Department of Public Health and Primary Care, University of Cambridge, Cambridge, England (Drs Bennet, Di Angelantonio, Erqou, and Danesh); Icelandic Heart Association, Kopavogur, Iceland (Ms Eiriksdottir and Drs Sigurdsson and Gudnason); University of Iceland, Reykjavik (Drs Sigurdsson and Gudnason); Department of Medicine, Mount Sinai Medical Center, New York, New York (Dr Woodward); and Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland (Drs Rumley and Lowe).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
The Emerging Risk Factors Collaboration
JAMA 2009;302:412-423.
ABSTRACT | FULL TEXT  

Mendelian Randomization: Nature's Randomized Trial in the Post-Genome Era
Thanassoulis and O'Donnell
JAMA 2009;301:2386-2388.
FULL TEXT  

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
Choy and Sattar
Ann Rheum Dis 2009;68:460-469.
ABSTRACT | FULL TEXT